Listen "Obesity drug sales soar"
Episode Synopsis
Eli Lilly easily beats sales forecasts. (0:16) DuPont boosts its dividend and launches buyback. (1:37) NYCB's head of risk left before it announced shock results. (2:38)Show NotesOppenheimer's Buy vs. Sell ideas paired by each SMID sectorDocuSign to shrink headcount; company will stay public after failed takeover talksEpisode transcripts seekingalpha.com/wsbSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
More episodes of the podcast Wall Street Breakfast
Another quantum computing first
06/01/2026
DHS calls out Hilton over ICE
06/01/2026
Fox's FanDuel boon
05/01/2026
Venezuela shift lifts energy shares
05/01/2026
Showtime for AI at CES Vegas
04/01/2026
A positive start for markets in 2026?
02/01/2026
Crack open a cold one for 2026
31/12/2025
Twelve headlines. One year. 2025
31/12/2025
Meta snaps up Manus
30/12/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.